Disulfiram (Antabuse), an acetaldehyde dehydrogenase and dopamine-beta hydroxylase inhibitor, has shown promise in preclinical and clinical studies as a pharmacotherapy for cocaine addiction. However, the extent to which disulfiram may alter the abuse-related behavioral effects of related psychostimulants, such as methamphetamine, is unknown. Here, the therapeutic potential of disulfiram was evaluated by examining its impact on the reinforcing and discriminative stimulus effects of d-methamphetamine in adult rhesus monkeys (N ϭ 4 per group). In subjects trained to respond for injections of methamphetamine or food delivery, i.v. methamphetamine (.001-.032 mg/kg) maintained dose-related and stable levels of self-administration in all subjects. Pretreatment with disulfiram (5.6 mg/kg) produced a significant downward shift in the d-methamphetamine dose-response function; surprisingly, lower and higher pretreatment doses (3.0 mg/kg; 10 mg/kg) were ineffective. Also, disulfiram (3-10 mg/kg) did not significantly alter food-maintained responding or, in subjects trained to discriminate the effects of cocaine from vehicle, the ability of d-methamphetamine (.032-.32 mg/kg) to substitute for cocaine. Taken together, the present data reveal dose-dependent effects of disulfiram in modifying some of the abuse-related effects of d-methamphetamine and provides support for future investigations examining the capacity of disulfiram as a treatment for d-methamphetamine abuse.
The abuse of monoaminergic stimulant drugs like cocaine and d-methamphetamine (d-MA) remains a significant health burden in the United States, and despite considerable effort, pharmacotherapeutics to counter their abuse have not yet been developed (Gonzales, Mooney, & Rawson, 2010) . Previous reports have indicated that cocaine's behavioral effects can be modulated by changes in neuronal norepinephrine (NE) activity, raising the possibility that drugs that directly or indirectly modulate NE levels, for example, uptake inhibitors or adrenoceptor agonists or antagonists, might be useful for the management of psychomotor stimulant abuse (reviewed by Weinshenker & Schroeder, 2007) . More recent support for this view has come from findings with the acetaldehyde dehydrogenase inhibitor disulfiram (Antabuse), which has been used as a pharmacotherapy to promote abstinence from alcohol (Skinner, Lahmek, Pham, & Aubin, 2014) . Disulfiram also has been shown to inhibit the ability of dopamine-beta hydroxylase (D␤H) to catalyze the conversion of dopamine (DA) to NE, which both decreases NE levels and indirectly increases DA levels in brain regions that have been implicated in addiction processes (Devoto et al., 2016; Schroeder et al., 2010) . Perhaps related to one or both of these neuropharmacological actions, disulfiram has recently been shown to also attenuate cocaine-seeking behavior in both rodent and human subjects, increasing interest in its utility for the management of psychomotor stimulant abuse (Carroll et al., 2004; Haile et al., 2012; Schroeder et al., 2010) . However, based on wellvalidated self-administration procedures, disulfiram thus far has been ineffective in modifying the reinforcing effects of cocaine in nonhuman primates (Cooper et al., 2014) . These differences in the effects of disulfiram may reflect differing procedures (i.e., reinstatement vs. self-administration) or, alternatively, species-related differences in either effectiveness or potency (Cooper et al., 2014; Haile et al., 2012; Schroeder et al., 2010) . The present study was undertaken to further investigate the potential utility of disulfiram for the management of psychomotor stimulant abuse by examining its ability to alter the reinforcing or discriminative stimulus effects of d-MA in rhesus monkeys that self-administered intravenous d-MA or, in a second group, discriminated intramuscular (IM) injections of cocaine from saline.
Method Animals
Adult rhesus monkeys (Macaca mulatta) had continuous access to water and were fed High Protein Monkey Diet (Purina Mills International, Brentwood, MO) chow, supplemented with fresh fruit; vegetables; and, during daily experimental sessions, 1-g bananaflavored pellets. Using previously described procedures (Kohut, Fivel, & Mello, 2013) , we surgically prepared each subject with an indwelling double lumen catheter in either a jugular or femoral vein. A 12-hr light-dark cycle was in effect throughout the period of study, and subjects lived in stainless steel housing with visual access to the colony room.
Animal care and research were conducted according to guidelines provided by the Institute of Laboratory Animal Resources and the National Institutes of Health Office of Laboratory Animal Welfare. The facility is licensed by the U.S. Department of Agriculture, and all experimental protocols were approved by the Institutional Animal Care and Use Committee at McLean Hospital. Enrichment outside experimental sessions was provided through access to mirrors and manipulable devices, music, and interactions with technical staff.
Self-Administration Procedure
Each daily 2-hr behavioral session occurred within the subject's home chamber and consisted of three response components separated by 5-min time-out (TO) periods. A pellet dispenser (Gerbrands Model G5210, Arlington, MA) and two syringe pumps (Model 981219, Harvard Apparatus, South Natick, MA) were positioned on a shelf above the home cage. During experimental sessions, a food cup attached to the front of the chamber allowed access to food pellets that were delivered from the pellet dispenser, and each syringe pump was configured to deliver a programmed volume into sterile tubing connected, in turn, to one lumen of the implanted double-lumen catheter. A custom-designed operant response panel containing three square translucent response keys arranged horizontally was also attached to the front of the chamber and was fully accessible to the subject during experimental sessions. Each response key could be illuminated with stimulus lights of differing color (SuperBright LEDs; Fairchild Seminconductor, San Jose, CA). During the first and last components of the experimental session, red lights illuminating the center response key signaled the availability of 1-g banana-flavored pellets for 5 min under a fixed ratio (FR) 10 to time-out (TO) 30-s (FR10: TO30-s) schedule of reinforcement. During the second (selfadministration) component, green lights illuminated the center response key, signaling the availability of intravenous injections of d-MA or saline for 100 min under the FR10:TO30-s schedule. This component was immediately preceded by illumination of a yellow light for 10 s encompassing the noncontingent delivery of a single priming injection (.3 ml over 3 s) of saline or the unit dose of d-MA that was subsequently available for intravenous self-administration. The yellow stimulus light also was illuminated during the short TO following each food or drug reinforcer delivery. During the 5-min intercomponent TO periods, all lights were off and responding had no scheduled consequences. All experimental events were controlled by a desktop PC running Med Associates (Med-PC IV, SOF-735, Med Associates, Fairfax, VT) software.
All monkeys (N ϭ 4) were previously trained to selfadminister cocaine under a double-alternation schedule (e.g., saline-saline, cocaine-cocaine, etc.; see Kohut et al., 2013) but had not received other drug treatments for at least 1 month. At the outset of the present study, d-MA replaced cocaine as the baseline self-administered drug. Subjects were maintained on d-MA under the same double-alternation sequence, and when d-MA-maintained responding was stable, dose-response functions for intravenous d-MA self-administration were determined in all subjects. Doses of d-MA were studied in random order, and full dose-response functions were determined by studying each dose of d-MA for at least two consecutive sessions in which the number of injections per session did not vary by Ϯ15%. After d-MA dose-response data were obtained, testing with disulfiram (3.0, 5.6, or 10 mg/kg) commenced. The unit dose of d-MA available for IV self-administration continued to vary under the double-alternation schedule. Data from the first session of the double alternation was used to confirm that IV self-administration of the unit dose of d-MA was stable, whereas the effects of disulfiram were determined by administering it prior to the second session of the double-alternation sequence. Disulfiram was administered intramuscularly 30 min prior to experimental sessions and was studied no more often than twice weekly in individual subjects. Test sessions were randomized in order and sequence among individual subjects.
Drug Discrimination Procedure
All monkeys (N ϭ 4) responded on an operant panel mounted to the front of their home chambers (described earlier). Right and left response keys on the operant panel could be illuminated with red or green stimulus lights. An externally mounted pellet dispenser that was attached to the back of the response panel delivered 1-g banana-flavored food pellets to a receptacle beneath the response panel.
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The present experiments were conducted in monkeys that previously were trained to discriminate cocaine (.4 mg/kg, IM) from saline under an FR30:TO10-s schedule of reinforcement (Kohut et al., 2017) . Briefly, response keys were differentially associated with the precomponent injection of saline or cocaine. During the component, completion of the FR requirement on the injectionassociated response key when stimulus lights were illuminated led to the delivery of a banana pellet followed by the 10-s TO. During the TO, stimulus lights were not illuminated and responding had no programmed consequences. Training sessions consisted of one to five cycles, and each cycle comprised a 15-min TO followed by a 5-min response component during which completion of the FR30:TO10-s schedule on the injection-associated key was reinforced; responses on the other key reset the FR requirement. Cocaine or saline (IM) was administered 10 min prior to the onset of each 5-min response component. During training, the number of cycles in the session varied daily on an irregular basis, and cocaine was administered during only the final cycle of a session; injections of saline were given during each preceding cycle. Testing commenced when the subject met the criterion for discrimination (Ͼ90% responding overall on the correct lever for four consecutive sessions). Test sessions were identical to training sessions except that responses on either lever were reinforced, and cumulative dosing procedures were used to determine dose-response functions. In the present experiments, the dose-effect function describing the ability of IM d-MA to substitute for cocaine was first determined in all subjects. Next, the ability of disulfiram to modify the effects of d-MA was studied by administering IM disulfiram (3.0, 5.6, and 10 mg/kg) 30 min prior to redetermining the d-MA dose-response function.
Drugs
Cocaine hydrochloride was supplied by the National Institute on Drug Abuse. d-Methamphetamine and disulfiram were obtained from Sigma-Aldrich (St. Louis, MO). Cocaine and d-MA were dissolved in sterile saline (.9% NaCl); disulfiram was suspended in 15% Tween 80 in water (vol/vol). Drug doses (mg/kg) are expressed as the salt.
Data Analysis
All statistics were conducted using GraphPad Prism Version 5.0 for Windows (La Jolla, CA). All data are expressed as the mean Ϯ standard error of the mean (SEM). Self-administration data are expressed as the mean (Ϯ SEM) number of injections per session. Self-administration of d-MA alone and in the presence of disulfiram was compared using two-way analyses of variance with Bonferroni posttest analyses where appropriate. Food-maintained responding in the absence and presence of disulfiram in selfadministration studies was compared using Student's paired t test. Discrimination data are expressed as percentage of the total number of responses made on the drug-associated lever; rates of responding (responses per second) are expressed as the mean (Ϯ SEM) for the group of subjects. The linear portion of dose-response functions for discrimination data were analyzed with linear regression. The slopes and intercepts of the d-MA drug discrimination functions alone and after disulfiram treatment were compared with an F ratio test (p Ͻ .05), and 50% effective dose (ED 50 ) values and 95% confidence intervals (CIs) were determined per Tallarida (2000) . ED 50 values were considered significantly different if 95% CIs did not overlap. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. Figure 1) .
Results

Self-Administration
Drug Discrimination
d-MA alone produced dose-related increases in responding on the cocaine-associated response key; the cumulative dose of .32 mg/kg MA engendered 99% cocaine-lever responding and did not significantly alter rates of responding (see Figure 2) . Averaged for the group of subjects, no dose of disulfiram significantly altered the discriminative stimulus effects of d-MA, F(6, 32) ϭ .41, p ϭ .86 (see Figure 2) . The averaged effects of 3.0 and 10.0 mg/kg disulfiram were relatively consistent among subjects, whereas the effects of 5.6 mg/kg disulfiram varied somewhat among individuals. Thus, pretreatment with 5.6 mg/kg disulfiram accentuated the cocaine-like discriminative-stimulus effects of d-MA in two subjects and either had no effect or attenuated the effects of d-MA in the remaining two subjects.
Discussion
Previous studies in human subjects have suggested that disulfiram may be useful for the management of cocaine abuse (Carroll et al., 2000; Haile et al., 2012) . However, preclinical studies have provided only mixed support for this idea. For example, studies in rats have shown that disulfiram may attenuate cocaine reinstatement following extinction but appears to enhance, rather than attenuate, the discriminative stimulus effects of cocaine (Manvich, DePoy, & Weinshenker, 2013; Schroeder et al., 2010) . Moreover, Cooper et al. (2014) reported that disulfiram failed to attenuate cocaine reinstatement in squirrel monkeys. The present findings, showing that an intermediate dose (5.6 mg/kg), but not lower or higher doses, of disulfiram consistently attenuated the reinforcing effects of d-MA but not its cocaine-like discriminative-stimulus effects, likely reflect a complex pharmacology.
Other studies have focused on D␤H inhibition as the primary mechanism through which disulfiram produces its effects, suggesting that a decrease in neuronal levels of NE may attenuate the abuse-related effects of psychomotor stimulant drugs. Some support for this view has come from observations that the noradrenergic actions of psychomotor stimulants may play a role in their discriminative-stimulus effects (Kleven & Koek, 1997; Spealman, 1995) . Although the ability of 5.6 mg/kg disulfiram to attenuate d-MA self-administration in the present experiments conceivably could be related to its ability to inhibit D␤H and increase NE levels in relevant brain regions, the biphasic dose-response relationship coupled with the lack of consistent effects of even this dose of disulfiram in drugdiscrimination experiments is not consistent with this analysis. Such considerations strongly support the idea that studies with more selective D␤H inhibitors such as nepicastat (Stanley et al., 1997) This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
in psychomotor stimulant abuse-related effects in nonhuman primates. In addition to its ability to partially reproduce or enhance the discriminative stimulus effects of cocaine in rodents, disulfiram has been reported to enhance the subjective effects of d-amphetamine in humans (Manvich et al., 2013; Sofuoglu et al., 2008) . Such effects of disulfiram in rodent and human subjects are consistent with its ability to moderately increase DA levels in the nucleus accumbens, which is thought to play a key role in the abuse-related effects of psychomotor stimulants (Devoto et al., 2016 ). Yet, in the present experiments, even the intermediate dose of disulfiram that attenuated d-MA self-administration did not reproduce or significantly alter the cocainelike discriminativestimulus effects of d-MA. Possibly, the failure of disulfiram to modulate the effects of d-MA is related to the training dose of cocaine and perhaps qualitatively different results would be obtained in subjects that were trained to discriminate MA from vehicle.
It is important to consider the disulfiram treatment regimen (e.g., time course and acute administration) used in the present report. Although a 30-min pretreatment interval was used in the present study, others have examined the effects of disulfiram 2 hr following its administration (Cooper et al., 2014) , due to its purported slow onset of activity (Di Ciano et al., 2018) . Attenuation of d-MA self-administration (at 5.6 mg/kg disulfiram) in the present study indicates that the 30-min pretreatment duration was likely sufficient for the expression of disulfiram's behavioral activity. However, the possibility that its effects might have been more pronounced in either self-administration or drug discrimination studies with a longer pretreatment time cannot be excluded and deserves further attention. Also, it is conceivable that disulfiram may have produced more robust effects in the present studies after repeated exposure, that is, if it had been administered in a chronic regimen. Indeed, several studies in humans have shown that daily treatment with disulfiram significantly decreases cocaine intake per week (Carroll et al., 2004) and that dose dependently decreases cocaine selfadministration in a cocaine versus money choice procedure (Haile et al., 2012) , suggesting that daily disulfiram treatment is effective in treating cocaine abuse. In this regard, future studies should also examine how chronic disulfiram treatment can modulate the abuse-related effects of d-MA. Parenthetically, it is important to note that chronic disulfiram decreases cocaine clearance and increases cocaine blood plasma levels (McCanceKatz, Kosten, & Jatlow, 1998) , which may contribute to the effectiveness of chronic disulfiram in attenuating cocaine's abuse-related behaviors. It is unclear whether similar pharmacokinetic interactions may exist between disulfiram and d-MA.
Finally, previous research has suggested that disulfiram significantly attenuates cocaine-primed reinstatement of cocaine self-administration (Schroeder et al., 2010) , suggesting that disulfiram's most advantageous use may lie in modulating relapse-related behaviors. Future studies are needed to determine whether disulfiram will attenuate d-MA primed reinstatement of d-MA self-administration. Results from this study indicate that acute administration of disulfiram has a limited therapeutic window, but more research is necessary to fully evaluate the conditions under which disulfiram may be effective as a pharmacotherapeutic to treat d-MA abuse.
